Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss
A Phase 1 Study of AG-270 in the Treatment of Subjects With Advanced Solid Tumors or Lymphoma With Homozygous Deletion of MTAP
Sponsor: Institut de Recherches Internationales Servier
Terminated
Strategic reasons
Other terminated trials from Institut de Recherches Internationales Servier
- IDH1-mutant Cholangiocarcinoma · Phase PHASE1/PHASE2 · Nov 2024
- Chronic Uveitis · Phase PHASE3 · Nov 2015
- Behcet's Uveitis · Phase PHASE3 · Sep 2015
- Mild Cognitive Impairment · Phase PHASE2 · Mar 2006
- Uveitis · Phase PHASE3
See all terminations from Institut de Recherches Internationales Servier
Other Advanced Solid Tumors trials with similar outcome
A PHASE1 clinical study on Advanced Solid Tumors and Lymphoma, this trial is terminated or withdrawn. The trial is conducted by Institut de Recherches Internationales Servier and has accumulated 39 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
39 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE1
-
Aug 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Jul 2024 — Aug 2024 [monthly]
Terminated PHASE1
-
Jun 2024 — Jul 2024 [monthly]
Terminated PHASE1
▶ Show 34 earlier versions
-
May 2024 — Jun 2024 [monthly]
Terminated PHASE1
-
Nov 2023 — May 2024 [monthly]
Terminated PHASE1
-
Jul 2023 — Nov 2023 [monthly]
Terminated PHASE1
Status: Completed → Terminated
-
Jun 2023 — Jul 2023 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Sep 2022 — Jun 2023 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Jul 2022 — Sep 2022 [monthly]
Recruiting PHASE1
-
Jun 2022 — Jul 2022 [monthly]
Recruiting PHASE1
-
Sep 2021 — Jun 2022 [monthly]
Recruiting PHASE1
-
Jun 2021 — Sep 2021 [monthly]
Recruiting PHASE1
-
May 2021 — Jun 2021 [monthly]
Recruiting PHASE1
-
Apr 2021 — May 2021 [monthly]
Recruiting PHASE1
-
Mar 2021 — Apr 2021 [monthly]
Recruiting PHASE1
-
Feb 2021 — Mar 2021 [monthly]
Recruiting PHASE1
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE1
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE1
-
Sep 2020 — Dec 2020 [monthly]
Recruiting PHASE1
-
Aug 2020 — Sep 2020 [monthly]
Recruiting PHASE1
-
Jul 2020 — Aug 2020 [monthly]
Recruiting PHASE1
-
Jun 2020 — Jul 2020 [monthly]
Recruiting PHASE1
-
May 2020 — Jun 2020 [monthly]
Recruiting PHASE1
-
Apr 2020 — May 2020 [monthly]
Recruiting PHASE1
-
Mar 2020 — Apr 2020 [monthly]
Recruiting PHASE1
-
Feb 2020 — Mar 2020 [monthly]
Recruiting PHASE1
-
Jan 2020 — Feb 2020 [monthly]
Recruiting PHASE1
-
Dec 2019 — Jan 2020 [monthly]
Recruiting PHASE1
-
Nov 2019 — Dec 2019 [monthly]
Recruiting PHASE1
-
Oct 2019 — Nov 2019 [monthly]
Recruiting PHASE1
-
Aug 2019 — Oct 2019 [monthly]
Recruiting PHASE1
-
Jul 2019 — Aug 2019 [monthly]
Recruiting PHASE1
-
May 2019 — Jul 2019 [monthly]
Recruiting PHASE1
-
Feb 2019 — May 2019 [monthly]
Recruiting PHASE1
-
Aug 2018 — Feb 2019 [monthly]
Recruiting PHASE1
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE1
-
Mar 2018 — Jun 2018 [monthly]
Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Institut de Recherches Internationales Servier
For direct contact, visit the study record on ClinicalTrials.gov .